(STOK) Stoke Therapeutics - Performance -18.7% in 12m
STOK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-59.18%
#84 in Peer-Group
Rel. Strength
24.04%
#5821 in Stock-Universe
Total Return 12m
-18.66%
#75 in Peer-Group
Total Return 5y
-46.65%
#62 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 14.2 |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 15.92 USD |
| 52 Week Low | 5.90 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 74.69 |
| Buy/Sell Signal +-5 | -0.09 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: STOK (-18.7%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: STOK vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for STOK
| Total Return (including Dividends) | STOK | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.86% | 4.10% | 4.77% |
| 3 Months | 56.88% | 13.70% | 16.02% |
| 12 Months | -18.66% | -12.86% | 12.44% |
| 5 Years | -46.65% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | STOK | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 41.3% | 52.1% | 90.3% |
| 3 Months | 88.2% | 79.4% | 97.5% |
| 12 Months | -74.3% | -87.4% | 46.4% |
| 5 Years | -75.2% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th49.00 | -1.19% | -1.82% |
| 3 Month | %th82.50 | 37.97% | 35.22% |
| 12 Month | %th63.00 | -6.65% | -27.66% |
| 5 Years | %th70.50 | -31.64% | -74.92% |
FAQs
Does Stoke Therapeutics (STOK) outperform the market?
No,
over the last 12 months STOK made -18.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months STOK made 56.88%, while XBI made 13.70%.
Performance Comparison STOK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
STOK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1% | -1.9% | 25.1% | -31% |
| US NASDAQ 100 | QQQ | 1.1% | -2.4% | 23.1% | -31% |
| German DAX 40 | DAX | 0.6% | -0.3% | 12.9% | -48% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.2% | -2.3% | 20.6% | -38% |
| Hongkong Hang Seng | HSI | 0.1% | -1.1% | 3.1% | -53% |
| India NIFTY 50 | INDA | 2.3% | 1.3% | 24.6% | -15% |
| Brasil Bovespa | EWZ | 5.2% | 3.2% | 10% | -19% |
STOK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.4% | -0.7% | 21.8% | -42% |
| Consumer Discretionary | XLY | 0.1% | -1.9% | 32.8% | -35% |
| Consumer Staples | XLP | 3% | 2.4% | 26% | -26% |
| Energy | XLE | -2% | 0.9% | 32.6% | -19% |
| Financial | XLF | 2.4% | -1.9% | 22.7% | -42% |
| Health Care | XLV | 0.8% | 3.1% | 36.6% | -12% |
| Industrial | XLI | 0.6% | -2.8% | 19.2% | -40% |
| Materials | XLB | 0.3% | -2.4% | 24.4% | -22% |
| Real Estate | XLRE | 1.2% | 2.7% | 26.6% | -26% |
| Technology | XLK | 1.1% | -4.3% | 20% | -29% |
| Utilities | XLU | 0.9% | 0.9% | 21% | -41% |
| Aerospace & Defense | XAR | 0.3% | -4.4% | 5.1% | -66% |
| Biotech | XBI | -2.7% | -1.2% | 35.3% | -6% |
| Homebuilder | XHB | -2.1% | -8.5% | 31.6% | -16% |
| Retail | XRT | 1.1% | -3.9% | 29.9% | -25% |
STOK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.4% | 6.51% | 39.0% | -15% |
| Natural Gas | UNG | 2.7% | 11.7% | 51.1% | -22% |
| Gold | GLD | 0.9% | 5.1% | 7.2% | -57% |
| Silver | SLV | -3.3% | -3.4% | 3% | -44% |
| Copper | CPER | -9.3% | -13.1% | 5.5% | -42% |
STOK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.9% | 3.1% | 30.4% | -15% |
| iShares High Yield Corp. Bond | HYG | 1.5% | 1.5% | 28.1% | -27% |